Experience unmatched diagnostic precision with our cutting-edge PCR Respiratory Pathogen Panel (RPP). Expertly designed to detect lung infections, our advanced panel leverages Applied Biosystem’s OpenArray Technology on QuantStudio 12K Flex instrumentation, accurately identifying pathogens to enable healthcare providers to prescribe targeted, evidence-based treatments.

Our comprehensive panel addresses a wide spectrum of bacterial, fungal, and viral targets, as well as relevant resistance genes, providing critical insights into conditions such as upper respiratory infections (including flu, COVID-19, and RSV) and pneumonia. With timely and precise diagnostics, our RPP not only alleviates patient discomfort but also prevents complications from prolonged infections, including symptom progression and the spread of contagious diseases.

RPP is a Laboratory Developed Test (LDT) using real-time PCR amplification of defined targets. While this test has not been cleared or approved by the FDA, Promus Diagnostics LLC is CLIA-certified to perform high-complexity clinical laboratory testing, ensuring it meets rigorous standards for clinical use.

Harness the power of our proprietary Promus Pathway and its validated reporting algorithm, delivering results with 95% sensitivity in CFUs/mL within just 24 hours. Our industry-leading treatment map sets a new standard in patient care, offering rapid, accurate, and actionable insights for superior clinical outcomes. Trust our expertise to elevate your diagnostic capabilities and enhance patient satisfaction.